Risk Analysis for Merck and Company: Product KL-798

Darden Business Publishing Cases

ISSN: 2474-7890

Publication date: 20 January 2017


This case builds on the case "Merck & Company: Product KL-798" (UVA-QA-0582) by providing market uncertainties for the drug (drug quality, the presence of a competitor, market growth, and the time to the drug's release). Student and faculty spreadsheets are provided for the calculation of net present values for the scenarios. There is an additional challenge of how to treat the several downstream decisions (using OptQuest, for example) and how to value the license opportunity. A teaching note is also available to registered faculty members.



Bodily, S. and Faulk, J. (2017), "Risk Analysis for Merck and Company: Product KL-798", Darden Business Publishing Cases. https://doi.org/10.1108/case.darden.2016.000262

Download as .RIS



University of Virginia Darden School Foundation

Copyright © 2003 by the University of Virginia Darden School Foundation, Charlottesville, VA. All rights reserved.

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.